Sawamura R, Fernandes M I, Galvão L C, Goldani H A
Department of Pediatrics, Faculty of Medicine of RibeirãoPreto, University of São Paulo, Brazil.
Arq Gastroenterol. 1996 Jul-Sep;33(3):179-81.
Two children with Budd-Chiari syndrome were successfully submitted to thrombolytic therapy. This study suggests that streptokinase is safe and effective in the treatment of this syndrome and should be considered as primary treatment in case of early diagnosed acute disease in view of the poor prognosis and the aggressiveness of surgical treatment currently available.
两名布加综合征患儿成功接受了溶栓治疗。本研究表明，链激酶治疗该综合征安全有效，鉴于目前手术治疗预后不佳且具有侵袭性，对于早期诊断的急性疾病，链激酶应被视为主要治疗方法。
